Suggest short May at money straddles to take advantage of the high premiums. I predict FDA will approve, but the share price won't move above 50. Target price Approval 50 (50%) Approval with tough restriction or post approval study 45 (25%) Request more data but no more new trial 38 or other delay (20%) More data new trial 22 (5%)
It always amazes me people think that readers should take positions based on recommendations from anonymous strangers on the internets.
I've also collected some short OTM put premiums on ITMN. We shall see the results very soon. (I was in DNDN too--hopefully it will be a replay of that: approval).
It's about time. I'm tired of looking at its super charged high IV quotes, trying to find a good hedged position that wins no matter what the stock does